Breast Cancer News

On average, breast cancer survivors get hit with an extra $1,100 in yearly out-of-pocket cancer-driven costs, researchers have found.

An experimental drug could improve survival for women with breast cancer who have the BRCA1 and BRCA2 gene mutations, a new study says.

The team also found that mutations in the BRIP1 and RAD51C genes were associated with a more moderate risk of triple-negative breast cancer.

Women who take the chemotherapy drug trastuzumab (Herceptin) for HER2-positive breast cancer can be at higher risk for heart failure and should have their hearts monitored during treatment, new research finds. The complication is not common, and in many cases, the benefits of the chemotherapy still outweigh the risks. But regular checks should be a priority.

Could More Vitamin D Help Prevent Breast Cancer? By Robert PreidtHealthDay Reporter WEDNESDAY, June 27, 2018 (HealthDay News) -- High levels of vitamin D may reduce a woman's risk of breast cancer, a new study suggests.Researchers looked at more than 5,000 women, 55 and older, and found that those with vitamin Dblood levels of 60 nanograms per milliliter (ng/mL) or more had an 80 percent lower risk for breast cancer than those with levels of 20 ng/mL or less.The researchers also found that among women with vitamin D blood levels between 20 and 60 ng/mL, the higher

Study Confirms Dense Breasts Are Prone to Cancer By Serena GordonHealthDay Reporter TUESDAY, June 26, 2018 (HealthDay News) -- Using automated breast density measurements, Norwegian researchers were able to more precisely confirm that women with dense breasts have a higher risk of breast cancer. The study included more than 100,000 women and more than 300,000 screening exams. "We found that screening examinations of women having dense breasts showed higher rates of recall and biopsy, and higher odds of screen-detected and interval breast cancers than women with non-dense breasts," said the study's senior author, Solveig Hofvind. She is

Besides demonstrating an ability to eliminate breast cancer, Rosenberg and his team already have additional preliminary results suggesting that the technique is similarly effective against both liver cancer and colon cancer.

The findings could be a game-changer in breast cancer care, researchers and experts said.

As the researchers explained, taselisib has already proven beneficial for people fighting head-and-neck cancers or certain gynecological tumors. Would it do the same for hormone-sensitive breast cancers?

Data from the Women's Health Initiative (WHI) study had already found that women who ate a low-fat diet were at lower odds of developing more aggressive forms of breast cancer.

Currently, the U.S. Preventive Services Task Force recommends that annual screenings start at age 50 for most women, while the American Cancer Society advises that annual screenings begin at age 45.

Swelling results when lymph vessels can't carry fluid away from the area, and it can lead to decreased range of movement and infection on the affected side.

BRCA1 and BRCA2 gene mutations put women at high risk for breast and ovarian cancers, but  these mutations also increase men's risk for certain cancers.

Those with more muscle had higher survival rates, regardless of their age or cancer stage, ABC News reported.

Genetic testing is already a billion-dollar industry, and some research estimates that it could grow to $10 billion in the next decade.

The disease -- breast implant-associated anaplastic large-cell lymphoma -- is not breast cancer. It's an immune system cancer that can usually be cured by surgery alone if detected early, The Times reported.

The average size of breast tumors at diagnosis fell 23 percent during that time -- from 26 millimeters to 20 millimeters (1.02 to 0.79 inches), the researchers found.

The study included just over 1,700 women with early stage breast cancer who could benefit from genetic testing.

U.S. Preventive Services Task Force guidelines recommend beginning breast cancer screening at age 50 for women at average risk. But it hasn't been clear if a single guideline can be applied to different racial or ethnic groups, the researchers noted.

The test, from 23andMe,  analyzes DNA from saliva collected by clients, the FDA said in an agency news release.

The study of more than 300 women who underwent breast radiation found that almost half had heard "frightening" stories going into treatment. But only 2 percent ultimately agreed that the stories were true.

In a study in Germany, the new technique reduced false-positive findings by 70 percent. The scan was also able to detect 98 percent of breast cancers correctly, the researchers said.

It's well-known that treatments such as chest radiation and certain drugs can damage the heart, sometimes leading to chronic heart disease.

After the rule went into effect, the study found, the number of women in Medicare Advantage plans who got mammography screening rose by 5.5 percentage points: from just under 60 percent in the two years before the rule, to 65.4 percent in the two years after.

BRCA mutations are inherited and increase the risk of breast and ovarian cancers. Between 45 percent and 90 percent of women with a BRCA mutation develop breast cancer, compared with about 12.5 percent of women in the general population.